Jazz Pharmaceuticals plc
SEC CIK 1232524 · JAZZ · last insider filing 2026-06-17
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Smith Mark Douglas | Director | filed 2020 - 2026 |
| Cozadd Bruce C | Director · Executive Chairman | filed 2007 - 2026 |
| Mulligan Seamus | Director · See Remarks | filed 2012 - 2026 |
| Winningham Rick E | Director | filed 2010 - 2026 |
| Mcsharry Heather Ann | Director | filed 2013 - 2026 |
| Riedel Norbert G | Director | filed 2013 - 2026 |
| Love TED W | Director | filed 2025 - 2026 |
| Enright Patrick G | Director | filed 2009 - 2026 |
| O'Keefe Kenneth W | Director | filed 2007 - 2025 |
| Hamill Laura | Director | filed 2024 - 2025 |
| Cook Jennifer E. | Director | filed 2020 - 2025 |
| Oriordan Anne | Director | filed 2019 - 2025 |
| Kennedy Patrick | Director | filed 2024 - 2025 |
| Sohn Catherine A. | Director | filed 2012 - 2023 |
| Gray Peter | Director | filed 2013 - 2023 |
| Berns Paul L | Director | filed 2010 - 2021 |
| Schnee Elmar | Director | filed 2014 - 2021 |
| Momtazee James C | Director | filed 2007 - 2013 |
| Cressey Bryan C | Director | filed 2007 - 2012 |
| Sebulsky Alan | Director | filed 2007 - 2012 |
| Michelson Michael W | Director | filed 2007 - 2012 |
| Colella Samuel D | Director | filed 2007 - 2012 |
| Zilkha Nathaniel M | Director | filed 2007 - 2011 |
| Myers Robert M | Director · President | filed 2007 - 2010 |
| Tananbaum James B | Director | filed 2007 - 2010 |
| Saks Samuel R | Director · Chief Executive Officer | filed 2007 - 2009 |
| Albert E Alexander | Director | filed 2008 - 2008 |
| Jaimin Patel | Director | filed 2007 - 2008 |
| Clammer Adam | Director | filed 2007 - 2007 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Patil Neena M | SVP, General Counsel | filed 2019 - 2026 |
| Gala Renee D | President & COO | filed 2020 - 2026 |
| Pearce Samantha | SVP, Head of Europe & Internat | filed 2020 - 2026 |
| Iannone Robert | EVP, Research & Development | filed 2019 - 2026 |
| Carr Patricia | VP, Finance& PAO | filed 2019 - 2026 |
| Henderson Mary Elizabeth | SVP, Technical Operations | filed 2023 - 2026 |
| Johnson Philip L | EVP & Chief Financial Officer | filed 2024 - 2026 |
| Sablich Kim | EVP, GM of U.S., Commercial Ma | filed 2020 - 2023 |
| Swisher Daniel N JR | President and COO | filed 2018 - 2023 |
| Larkin Finbar | SVP, Technical Operations | filed 2019 - 2023 |
| Tovey Christopher J. | EVP, COO & Managing Director E | filed 2021 - 2022 |
| Miller Michael Patrick | SVP, US Commercial | filed 2014 - 2020 |
| Treacy Paul | SVP, Technical Operations | filed 2014 - 2019 |
| Wilson Karen J | VP, Finance & PAO | filed 2011 - 2019 |
| Young Matthew P. | SVP & CFO | filed 2014 - 2019 |
| Mcgill Iain | SVP, Europe and Rest of World | filed 2014 - 2019 |
| Hooper Suzanne Sawochka | EVP and General Counsel | filed 2012 - 2019 |
| Smith Karen L. | Global Head of R&D and CMO | filed 2015 - 2018 |
| Cox Russell J. | SVP, Sales and Marketing | filed 2011 - 2017 |
| Tobias Jeffrey K | SVP of Research & Dev and CMO | filed 2011 - 2015 |
| Keegan Fintan | EVP, Technical Operations | filed 2012 - 2014 |
| Falberg Kathryn E | SVP and CFO | filed 2009 - 2014 |
| Gamble Carol A | SVP, GC and Secretary | filed 2007 - 2012 |
| Desjardin Michael A. | SVP, Product Development | filed 2011 - 2011 |
| Eller Mark G. | SVP, Research & Clinical Dev. | filed 2011 - 2011 |
| Wissel Janne LT | Senior VP of Development | filed 2007 - 2011 |
| Colligan Joan | Principal Accounting Officer | filed 2009 - 2010 |
| Fust Matthew K | Senior Vice President & CFO | filed 2007 - 2008 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.